Use of hypoglycemic drugs during lactation. Export

@article{citeulike:5679645, abstract = {QUESTION: My patient was taking glipizide (an oral sulfonylurea) for type 2 diabetes. Now she is pregnant and taking insulin instead. She is very anxious to return to her previous treatment immediately after delivery because of the pain and hurdles associated with the administration of insulin. Can sulfonylureas cross into human milk and, if so, is it safe for her to breastfeed her infant? ANSWER: The exposure of infants to second-generation sulfonylureas (eg, glipizide, glyburide) through breast milk is expected to be minimal, based on the limited data available. Women with type 2 diabetes treated with sulfonylureas should not be discouraged from breastfeeding. The benefits of breastfeeding greatly outweigh the risks of these medications, if any. The baby should, however, be monitored for signs of hypoglycemia.}, author = {Glatstein, Miguel Marcelo M. and Djokanovic, Nada and Garcia-Bournissen, Facundo and Finkelstein, Yaron and Koren, Gideon}, citeulike-article-id = {5679645}, citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/19366943}, citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=19366943}, issn = {1715-5258}, journal = {Canadian family physician M\'{e}decin de famille canadien}, keywords = {breastfeeding}, month = {April}, number = {4}, pages = {371--373}, posted-at = {2009-08-29 20:59:18}, priority = {2}, title = {Use of hypoglycemic drugs during lactation.}, url = {http://view.ncbi.nlm.nih.gov/pubmed/19366943}, volume = {55}, year = {2009} }

TY - JOUR ID - citeulike:5679645 L3 - citeulike-article-id:5679645 N2 - QUESTION: My patient was taking glipizide (an oral sulfonylurea) for type 2 diabetes. Now she is pregnant and taking insulin instead. She is very anxious to return to her previous treatment immediately after delivery because of the pain and hurdles associated with the administration of insulin. Can sulfonylureas cross into human milk and, if so, is it safe for her to breastfeed her infant? ANSWER: The exposure of infants to second-generation sulfonylureas (eg, glipizide, glyburide) through breast milk is expected to be minimal, based on the limited data available. Women with type 2 diabetes treated with sulfonylureas should not be discouraged from breastfeeding. The benefits of breastfeeding greatly outweigh the risks of these medications, if any. The baby should, however, be monitored for signs of hypoglycemia. IS - 4 JF - Canadian family physician Médecin de famille canadien SN - 1715-5258 EP - 373 TI - Use of hypoglycemic drugs during lactation. VL - 55 SP - 371 KW - breastfeeding AU - Glatstein, Miguel Marcelo AU - Djokanovic, Nada AU - Garcia-Bournissen, Facundo AU - Finkelstein, Yaron AU - Koren, Gideon PY - 2009/04// UR - http://view.ncbi.nlm.nih.gov/pubmed/19366943 ER -